News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,085 Results
Type
Article (40022)
Company Profile (292)
Press Release (651771)
Section
Business (204687)
Career Advice (2004)
Deals (35497)
Drug Delivery (92)
Drug Development (81211)
Employer Resources (168)
FDA (16189)
Job Trends (14868)
News (346053)
Policy (32586)
Tag
Academia (2551)
Alliances (49457)
Alzheimer's disease (1269)
Approvals (16153)
Artificial intelligence (146)
Bankruptcy (356)
Best Places to Work (11619)
Biotechnology (208)
Breast cancer (191)
Cancer (1396)
Cardiovascular disease (123)
Career advice (1669)
Cell therapy (286)
Clinical research (64994)
Collaboration (493)
Compensation (275)
COVID-19 (2550)
C-suite (109)
Data (1399)
Diabetes (182)
Diagnostics (6189)
Earnings (85098)
Employer resources (146)
Events (110639)
Executive appointments (406)
FDA (16887)
Funding (441)
Gene therapy (201)
GLP-1 (621)
Government (4347)
Healthcare (18776)
Infectious disease (2643)
Inflammatory bowel disease (112)
Interviews (310)
IPO (16390)
Job creations (3650)
Job search strategy (1422)
Layoffs (422)
Legal (7886)
Lung cancer (201)
Lymphoma (100)
Manufacturing (207)
Medical device (13270)
Medtech (13275)
Mergers & acquisitions (19291)
Metabolic disorders (474)
Neuroscience (1594)
NextGen Class of 2024 (6525)
Non-profit (4477)
Northern California (1727)
Obesity (270)
Opinion (185)
Patents (122)
People (56713)
Phase I (20201)
Phase II (28606)
Phase III (21343)
Pipeline (516)
Postmarket research (2590)
Preclinical (8590)
Radiopharmaceuticals (236)
Rare diseases (267)
Real estate (5927)
Regulatory (21804)
Research institute (2330)
Resumes & cover letters (350)
Southern California (1479)
Startups (3584)
United States (15460)
Vaccines (568)
Weight loss (191)
Date
Last 7 days (171)
Last 30 days (1605)
Last 365 days (34638)
2025 (91)
2024 (35372)
2023 (40189)
2022 (51318)
2021 (55848)
2020 (54233)
2019 (46686)
2018 (35130)
2017 (32252)
2016 (31668)
2015 (37752)
2014 (31563)
2013 (26607)
2012 (28802)
2011 (29509)
2010 (27714)
Location
Africa (715)
Arizona (198)
Asia (37632)
Australia (6170)
California (3885)
Canada (1474)
China (324)
Colorado (174)
Connecticut (180)
Europe (80793)
Florida (553)
Georgia (136)
Illinois (390)
Indiana (227)
Maryland (643)
Massachusetts (3013)
Michigan (175)
Minnesota (298)
New Jersey (1124)
New York (1105)
North Carolina (765)
Northern California (1727)
Ohio (148)
Pennsylvania (947)
South America (1095)
Southern California (1479)
Texas (562)
Utah (108)
Washington State (405)
692,085 Results for "cardiovascular biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
Bayer’s Kidney Disease Drug Kerendia Reduces Cardiovascular Risk by 16%
Bayer’s Kerendia, at the center of a $3 billion sales forecast, reduced the risk of cardiovascular death and heart failure in a Phase III trial.
September 3, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
October 18, 2024
·
4 min read
Drug Development
Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced plans to advance investigational plozasiran into a Phase 3 cardiovascular outcomes trial called CAPITAN.
June 25, 2024
·
12 min read
Press Releases
Inagene Diagnostics Inc. Launches Canada’s Most Comprehensive Genetic Test for Cardiovascular Medications, Highlighting Major Gaps in Heart Medication Awareness
October 25, 2024
·
3 min read
Press Releases
Xentria Announces Exclusive Licensing Agreement with New York University to Advance a Disease-Modifying Cardiovascular Therapy Globally
December 19, 2024
·
2 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Business
Cardurion Raises $260M to Advance Cardiovascular Assets
Backed by Bain Capital, Cardurion Pharmaceuticals will use the Series B funds to advance two assets for heart failure and other cardiovascular conditions.
July 16, 2024
·
1 min read
·
Tyler Patchen
Press Releases
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
December 17, 2024
·
6 min read
Press Releases
Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
November 18, 2024
·
2 min read
Bio NC
Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium
Milestone ® Pharmaceuticals Inc. today announced that it will present data on etripamil at the 30th Annual Cardiovascular Nursing Symposium held by the Preventive Cardiovascular Nurses Association on April 18-20th in Orlando, FL.
April 17, 2024
·
1 min read
1 of 69,209
Next
